News

Nelipak Healthcare Packaging Honored with a 2021 AmeriStar Award

Company’s Miltenyi CliniMACS Prodigy® Tubing Set Recognized in Medical Device Category

Cranston, RI – August 4, 2021 – Nelipak® Corporation (“Nelipak”), a global leader in rigid and flexible packaging for the medical device and pharmaceutical sectors, has been recognized with a 2021 AmeriStar Award in the medical device category for the company’s work on the Militenyi CliniMACS Prodigy® tubing set.

The AmeriStar Awards, presented by the Institute of Packaging Professionals, are one of the industry’s oldest and most prestigious design competitions honoring the best packages of the year. Judges evaluated submissions based on performance in the following categories: innovation, product protection, economics, package performance, marketing and environmental impact.

Nelipak Healthcare Packaging has created an innovative package for a blood management tubing set for its customer Miltenyi Biotec. The thermoformed carrier allows the product to be shipped with all the components assembled in the correct order, in the correct place, making it possible for a single person to load the complex set. The package folds into itself to be in the right position, so the technician can place the pack onto the machine, and everything is presented correctly. The packaging provides clear, error-free application of the tubing set to the CliniMACS Prodigy® Instrument speeding up preparation time between batches.

The packaging properly protects and secures the product, so items are not damaged during transit. The package’s sustainable ergonomic design reduces the materials used while retaining the CliniMACS Prodigy® tubing set in place. As an alternative to printing, the instructions that indicate how the tubing must be connected are engraved to ensure that the material is recyclable. The volume is utilized, and the seal width is reduced to a minimum in order to reduce plastics, save plastic weight and decrease the footprint of the packaging.

“The Nelipak Healthcare Packaging team is grateful to be acknowledged in the AmeriStar Awards for our innovative design,” said Bob Jacobs, Team Leader Product Design, Nelipak. “As a global leader in designing custom healthcare packaging to meet medical device manufacturers’ most stringent requirements, we are fortunate to collaborate with companies such as Miltenyi Biotec to create cutting-edge solutions.”

###

About Nelipak® Healthcare Packaging

Nelipak Healthcare Packaging is a leading global manufacturer of custom-designed rigid and flexible healthcare packaging used for Class II and Class III medical devices, and pharma drug delivery products. The company operates strategically located cleanroom facilities meeting customers’ most stringent packaging requirements. Nelipak’s experienced in-house design, development, prototyping, manufacturing and quality teams offer medical trays and blisters, surgical procedure trays, flexible sterile tray lidding and barrier pouches, pharmaceutical handling trays, custom built sealing machines and other value-added services. With a staff of over 1,400, the company operates from ten production facilities, five in the Americas (Cranston, RI.; Whitehall, PA; Phoenix, AZ.; Humacao, Puerto Rico; and San Jose, Costa Rica) and five in Europe (Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; and Elsham, England). For more information, please visit omsneladoptprd.wpenginepowered.com.

Nelipak® Healthcare Packaging is a trade name of Nelipak Corporation.

Follow us on:

Twitter: www.twitter.com/nelipak1953 
LinkedIn: https://www.linkedin.com/company/nelipak
YouTube: www.youtube.com/user/nelipakhealthcare

Nelipak Marketing Contact:
Seán Egan
Director of Global Marketing
Nelipak Healthcare Packaging
+353-91-709-163
sean.egan@nelipak.com

Press Contact:
Sage Morander
SVM Public Relations
sage.morander@svmpr.com

                

Nelipak Laboratory Services Details Package Integrity Testing Process

Ensures Sterility and Integrity of Products, Which Can Have a Major Impact on Patients’ Health

Clara, Ireland – July 28, 2021 – Nelipak® Laboratory Services (“Nelipak”), a leading provider of healthcare packaging testing for the medical device and pharmaceutical sectors, provides further details on the company’s package integrity testing process.

Previously, the team detailed visual inspection and dye penetration tests. Package integrity is a major concern for all manufacturers particularly ones in the medical device industry where the sterility and integrity of products can have a major impact on patients’ health.

In the second part of this series, we will examine two common tests often used to determine package seal integrity – bubble leak and seal strength. Nelipak Laboratory Services, a fully ISO 17025 accredited lab, provides testing services to healthcare companies from all manufacturing sectors.

Bubble leak testing, which is carried out at Nelipak Laboratory Services to the ASTM Standard F2096, is one of the most common tests done to examine the integrity of packaging materials. While similar to dye penetration testing, bubble leak testing has a distinct advantage as it can detect the presence of holes not only in the product seal but also the main body of the packaging, which dye penetration testing may not detect. A destructive test by nature, bubble leak testing works by inflating the packaging underwater to a certain pressure and checking for the presence of streams of bubbles coming from the surfaces of the packaging. A continuous stream of bubbles is an indication of a breach in package barrier integrity in the packaging.

Seal strength testing (also referred to as a peel test) is a test performed to measure the strength of the seal of a package. The method at Nelipak (based on standard ASTM Standard F88/F88M) determines the peel force required to separate the seal. The results of this test have many helpful applications such as a review of a sealing process to ensure a consistent seal has been produced or checking that a seal produced is not too weak or too strong. There are several methods used to perform seal strength depending on the material and packaging type. However, the basic principle remains the same. A sample of the seal is cut from the package, often one from each seal of the package, and placed between two grips. The seal strength tester measures the forces as the two grips pull the seal apart and an average value is calculated. This seal strength value can then be used to determine if the sealing process is both consistent and strong enough for the customer’s needs.

For further information regarding package integrity testing and other services, contact the Nelipak Laboratory Services team at cla-labservices@nelipak.com  or go to our website.

###

About Nelipak® Corporation

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; Elsham, United Kingdom; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak® Healthcare Packaging designs, develops and manufactures custom packaging products that provide superior protection for medical devices and pharmaceuticals.   Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world.  With over 1,400 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak® Laboratory Services is a trade name of Nelipak Corporation

Follow us on:

Twitter: www.twitter.com/nelipak1953 
LinkedIn: https://www.linkedin.com/company/nelipak
YouTube: www.youtube.com/user/nelipakhealthcare

Nelipak Marketing Contact:
Seán Egan
Director of Global Marketing
Nelipak Healthcare Packaging
+353-91-709-163
sean.egan@nelipak.com

Press Contact:
Sage Morander
SVM Public Relations
sage.morander@svmpr.com

                

Nelipak Laboratory Services Provides Package Integrity Testing

Ensures Sterility and Integrity of Products, Which Can Have a Major Impact on Patients’ Health

Clara, Ireland June 18, 2021 Nelipak® Laboratory Services (“Nelipak”), a leading provider of healthcare packaging testing for the medical device and pharmaceutical sectors, provides package integrity testing services at our Clara, Ireland and Venray, the Netherlands locations for healthcare companies from all manufacturing sectors.

Package integrity is a major concern for manufacturers, particularly those in the medical device and pharmaceutical industries where the sterility and integrity of products can have a major impact on patients’ health. Two of the most common package integrity tests that our team performs for customers are visual inspection and dye penetration.

The visual inspection of products (performed at Nelipak Labs to the ASTM F1886/F1886M standards) is the most common way to check for package integrity across multiple industries. Visual inspection, though a simple test, provides very useful information for a manufacturer to uncover potential failures in their packaging process. ASTM F1886/F1886M focuses mainly on identifying visual characteristics of package seals, which can indicate a possible problem with the integrity of the package sealing process.

A full inspection of the seal and package involves the identification of abnormal characteristics in the package such as unsealed areas, narrow seals, over-sealed areas, channels in seals, cracks, wrinkles, tears, holes or contaminates. Customers often provide additional internal criteria for their inspection such as label legibility, device damage, specific seal widths, etc.

Dye penetration testing (carried out at Nelipak Labs to the ASTM F1929 standard for porous materials and ASTM F3039 standard for non-porous materials) is frequently performed to ensure the seals of a pouch or blister pack are uniform and whole. This test helps manufacturers determine if their sealing process or a package supplier’s sealing process is fit for purpose.

This test works to identify channels indicating an integrity issue in the package seal using a coloured dye solution. The procedure involves a variety of methods to test different types of packaging such as injection method, edge dip, and roller method. All the methods look for the same criteria to see if the dye solution passes through the seal of the package at any point. The passing of the dye solution through the seal indicates the presence of a channel, which means the seal of the package is not whole across the package.

For further information on package integrity testing services, contact the Nelipak Laboratory Services team at cla-labservices@nelipak.com  or visit our website.

###

About Nelipak® Corporation

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; Elsham, United Kingdom; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak® Healthcare Packaging designs, develops and manufactures custom packaging products that provide superior protection for medical devices and pharmaceuticals.   Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world.  With over 1,400 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak® Laboratory Services is a trade name of Nelipak Corporation

Follow us on:

Twitter: www.twitter.com/nelipak1953 
LinkedIn: https://www.linkedin.com/company/nelipak
YouTube: www.youtube.com/user/nelipakhealthcare

Nelipak Marketing Contact:
Seán Egan
Director of Global Marketing
Nelipak Healthcare Packaging
+353-91-709-163
sean.egan@nelipak.com

Press Contact:
Sage Morander
SVM Public Relations
sage.morander@svmpr.com

                

Nelipak Laboratory Services Successfully Completes ISO 17205 Accreditation Maintenance Audit for 2021

Clara, Ireland May 24, 2021 Nelipak® Laboratory Services (“Nelipak”), a leading provider of healthcare packaging testing for the medical device and pharmaceutical sectors, recently successfully completed its annual ISO 17025 maintenance audit continuing its accreditation to the ISO 17025 standard.

This mark’s Nelipaks’ 12th consecutive year of successful accreditation to the ISO standard, which details the requirements (both technical and quality) that testing and calibration laboratories must adhere to. For an organization to be accredited in ISO 17025, its laboratory must be able to consistently produce precise, repeatable and accurate tests and have implemented a rigorous quality management system.

The successful completion of this audit demonstrates that Nelipak Laboratory Services holds both technical and quality aspects of its laboratory and testing to the highest level. Continued accreditation to the ISO 17205 standard also gives our customers the assurance that testing is performed to the highest standards and they can have full confidence in our results.

Nelipak Laboratory Services offers ISO 17205 accredited testing to all commercial customers. We offer a range of testing activities including accelerated aging, transport simulation testing, material analysis and package integrity Ttsting.

Nelipak Laboratory Services offers a comprehensive range of tests, including aging, package and material testing, transportation and analytical testing for the medical device, pharmaceutical, packaging and life science industries. In addition to providing high quality testing and analysis, our team of experts have considerable experience in advising, problem solving and consulting on all aspects of packaging regulation and standards. We are committed to achieving and maintaining a high standard of quality and service in all aspects of our laboratory testing. This commitment is underpinned by the support of our management team to provide a highly professional and confidential service in our secure facility to all our customers.

For any queries regarding our testing options and to receive quote please contact us at cla-labservices@nelipak.com

###

About Nelipak® Corporation

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; Elsham, United Kingdom; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak® Healthcare Packaging designs, develops and manufactures custom packaging products that provide superior protection for medical devices and pharmaceuticals.   Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world.  With over 1,400 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak® Laboratory Services is a trade name of Nelipak Corporation

Follow us on:

Twitter: www.twitter.com/nelipak1953 
LinkedIn: https://www.linkedin.com/company/nelipak
YouTube: www.youtube.com/user/nelipakhealthcare

Nelipak Marketing Contact:
Seán Egan
Director of Global Marketing
Nelipak Healthcare Packaging
+353-91-709-163
sean.egan@nelipak.com

Press Contact:
Sage Morander
SVM Public Relations
sage.morander@svmpr.com

                

Nelipak Laboratory Services Details Transportation Testing Process

Lab is Fully INAB Accredited for a Full Range of Transportation Simulation Tests

Clara, Ireland April 27, 2021 Nelipak® Laboratory Services (“Nelipak”), a leading provider of healthcare packaging testing for the medical device and pharmaceutical sectors, provides further details on the company’s transportation testing services.

Previously, the team detailed the first half of transport simulation testing for the ASTM Standard D4169, which focused on the DC13 cycle in particular as it is one of the most commonly selected cycles a company may choose when looking to perform transportation testing for their product.

Now, here is a closer look at DC13 Loose Load vibration Schedule F. This test involves the vibration of the shipper box to simulate the shocks a box undergoes during any form of transportation. Shipper boxes are vibrated on different box orientations to fully test the ability of the shippers to protect their contents during transport.

Following the vibration test, comes Schedule I Low pressure testing, also known as High-Altitude testing. The examines the effects of high-altitude transportation (such as air transport or along high mountain roads). The reduction in pressure under those conditions can cause packaging materials to inflate due to the pressure difference. Shippers are placed in a chamber under reduced atmospheric pressure for an hour to determine if the packaging can withstand the pressure change. This test is only required for non-porous packaging materials as porous (also known as breathable materials) can allow air to pass through them so changes in pressure do not affect them.

Next, another vibration test takes place. Vehicle Vibration Schedule E is similar to Loose Load vibration; however, this specifically simulates the vibrations known to occur during certain transport methods. The most common types are road, air and rail, and depending on the method a shipper may be transported in, different combinations can be selected. These vibration tests are run for several hours to determine if shippers can withstand the shocks and movement of a vehicle moving in transport.

The next to last test that may be performed is Concentrated Impact Schedule J. This test is only necessary for single-walled shippers (double or triple-walled shippers can be exempt from this test). The protocol involves a large cylinder rod being raised and dropped striking the faces of the shipper box to determine if the shipper can remain undamaged following a concentrated collision with another object. In cases when the rod pierces the inner shipper, it is considered to have failed the test.

The final step in transportation simulation for DC13 is another round of drop testing. These drops are very similar to the second step explained earlier but differ as a new set of sides and edges of the shipper boxes are tested during these drops to understand what damage is caused to the box after all other tests have been completed. The final drop of this sequence is the largest, at double the height of all the other drops.

This concludes the second half of a typical transportation simulation testing cycle. For further information regarding accelerated aging and other services, contact the Nelipak Laboratory Services team at info@nelipak.com or go to our website.

###

About Nelipak® Corporation

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; Elsham, United Kingdom; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak® Healthcare Packaging designs, develops and manufactures custom packaging products that provide superior protection for medical devices and pharmaceuticals.   Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world.  With over 1,400 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak® Laboratory Services is a trade name of Nelipak Corporation

Follow us on:

Twitter: www.twitter.com/nelipak1953 
LinkedIn: https://www.linkedin.com/company/nelipak
YouTube: www.youtube.com/user/nelipakhealthcare

Nelipak Marketing Contact:
Seán Egan
Director of Global Marketing
Nelipak Healthcare Packaging
+353-91-709-163
sean.egan@nelipak.com

Press Contact:
Sage Morander
SVM Public Relations
sage.morander@svmpr.com

                

Nelipak Laboratory Services Offers Transportation Testing

Equipment Meets Increased Customer DeLab is Fully INAB Accredited for a Full Range of Transportation Simulation Tests

Clara, Ireland March 23, 2021 Nelipak® Laboratory Services (“Nelipak”), a leading provider of healthcare packaging testing for the medical device and pharmaceutical sectors, offers testing for Transportation Simulation, a vitally important test for most companies and commonly based on ASTM Standard D4169 (Performance Testing of Shipping Containers and Systems).

Companies take great care to ensure their products are in perfect condition when they are ready to ship. However, as soon as shippers leave the site, the product is now outside of the company’s control and can be handled less than ideally during transport. Therefore, it is important that companies know that their products are packaged in a strong packaging system to ensure they remain undamaged even through rough transportation. Transportation testing involves a series of assessments designed to simulate various transportation stresses placed on shipper boxes during a worst-case transportation cycle to ensure that products remain fit for use even in a worst-case scenario.

The first half of Distribution Cycle 13 from ASTM D4169 T is preferred by many companies, as it simulates international transportation by both air and motor transportation, a common transportation system for many companies. The first step of this testing is climatic conditioning, a simulation of weather conditions of the shipper boxes. For more information on climatic conditioning, click here.

The next step of testing is Schedule A Handling, which is based on Standard ASTM D5276. This rather simple test involves dropping the shippers from a fixed height to simulate shippers which are dropped or fall during transportation. Drops are performed from a range of sides and edges of the shippers to test for every type of fall. The shipper is then thoroughly examined for signs of damage to the shipper.

After handling comes Schedule C Vehicle Stacking, which is based on ASTM Standard D642. This test is designed to simulate the effects of a shipper box having other shippers packed on top of it, which can put a significant weight on the shipper and damage product within. The test involves calculating a weight that the shipper may be exposed to and placing it on the shipper to see if any damage is caused by the weight pressing down on the shipper box.

For further information regarding testing of accelerated aging and other services, contact the Nelipak Laboratory Services team at cla-labservices@nelipak.com  or go to our website.

###

About Nelipak® Corporation

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; Elsham, United Kingdom; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak® Healthcare Packaging designs, develops and manufactures custom packaging products that provide superior protection for medical devices and pharmaceuticals.   Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world.  With over 1,400 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak® Laboratory Services is a trade name of Nelipak Corporation

Follow us on:

Twitter: www.twitter.com/nelipak1953 
LinkedIn: https://www.linkedin.com/company/nelipak
YouTube: www.youtube.com/user/nelipakhealthcare

Nelipak Marketing Contact:
Seán Egan
Director of Global Marketing
Nelipak Healthcare Packaging
+353-91-709-163
sean.egan@nelipak.com

Press Contact:
Sage Morander
SVM Public Relations
sage.morander@svmpr.com

                

Nelipak Customer CorNeat Vision Successfully Implants First Artificial Cornea

Equipment Meets Increased Customer Demand for Condition TestingNelipak Provides Blister Package for Ground-breaking CorNeat KPro

Nelipak® Healthcare Packaging (“Nelipak”), a global leader in rigid and flexible packaging for the medical device and pharmaceutical sectors, in partnership with Yail Noa Group, a leader in innovative technological protection solutions, congratulates our customer CorNeat Vision on the successful implantation of the CorNeat KPro, the first artificial cornea which completely integrates with the eye wall with no reliance on donor tissue. CorNeat Vision is a biomimetic implant and technology company, which produces a lineup of innovative, safe, affordable and long-lasting ophthalmic medical solutions that will significantly impact surgery practices in the areas of ophthalmology, periodontology and more.

The surgery, which was performed on a bilaterally blind, 78-year-old male at Rabin Medical Center, Israel, by Professor Irit Bahar, Director of the Ophthalmology Department, can be watched here and shows Nelipak’s blister and packaging in the operating room. The CorNeat KPro enabled the patient to read text and recognize family members, after a decade of blindness.

Nelipak is proud to develop and provide blisters for CorNeat Vision, as well as have our team perform validation work on the blister and Tyvek® used. Our blisters provide product protection and security, and our team leverages our extensive knowledge to design and manufacture the most user-friendly and optimized packs. Our custom packaging solutions are 100% focused on healthcare, so we can provide the protection that CorNeat Vision needs to deploy its ground-breaking solution. We drive our customers’ success by combining superior quality, customer support and the most efficient technology.

To learn more about how Nelipak meets medical device and pharmaceutical manufacturers’ most stringent packaging requirements, visit https://www.nelipak.com.

About CorNeat Vision

CorNeat Vision is a clinical-stage, biomimetic implant technology company. CorNeat Vision’s platform is a 100% synthetic, non-degradable porous material, which mimics the micro-structure of the Extracellular Matrix (ECM) – the natural biological collagen mesh providing structural and biochemical support to surrounding cells. When implanted, this material stimulates cellular proliferation, leading to progressive tissue integration. This fully validated in-vivo platform enables the bio-mechanical integration of permanent implants with live tissue and does not trigger an adverse immune system response. Click HERE to learn more.

About Nelipak® Healthcare Packaging

Nelipak Healthcare Packaging is a leading global manufacturer of custom-designed rigid and flexible healthcare packaging used for Class II and Class III medical devices, and pharma drug delivery products. The company operates strategically located cleanroom facilities meeting customers’ most stringent packaging requirements. Nelipak’s experienced in-house design, development, prototyping, manufacturing and quality teams offer medical trays and blisters, surgical procedure trays, flexible sterile tray lidding and barrier pouches, pharmaceutical handling trays, custom built sealing machines and other value-added services. With a staff of over 1,400, the company operates from ten production facilities, five in the Americas (Cranston, RI.; Whitehall, PA; Phoenix, AZ.; Humacao, Puerto Rico; and San Jose, Costa Rica) and five in Europe (Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; and Elsham, England).  For more information, please visit omsneladoptprd.wpenginepowered.com.

Nelipak® Healthcare Packaging is a trade name of Nelipak Corporation

          

Nelipak Laboratory Services Offers Accelerated and Real-Time Aging Testing

Equipment Meets Increased Customer Demand for Condition Testing

Clara, Ireland February 15, 2021 Nelipak® Laboratory Services (“Nelipak”), a leading provider of healthcare packaging testing for the medical device and pharmaceutical sectors, now offers a range of accelerated and real-time aging testing to determine the shelf life of products, which is a major part of medical device manufacturers’ product development process.

Sterile products, which must maintain a sterile barrier over long periods of time, are vital in the medical industry. It is rarely feasible to perform only real-time aging of a product in order to determine its suitability for use after several years. Therefore, other options must be considered. Due to the need to get a product to market as quickly as possible, accelerated aging is a common solution, and Nelipak’s accelerated aging testing enables quicker product development our customers.  

Based on the ASTM standard F1980, this testing allows a product to be stored under a set temperature over a specified period of time. This extra stress, which is more severe than normal environmental conditions, causes an accelerated variation in the packaging properties over time. Using the Arrhenius equation, a temperature can be selected to calculate a time period for accelerated aging. For example, a product normally stored at 23°C which undergoes accelerated aging at 50°C would be equivalently aged one year after only 57 days or five years after 281 days.

Nelipak Laboratory Services offers a range of accelerated aging chambers set at a variety of controlled temperatures to suit our customers’ accelerated aging needs. The chambers are also set at controlled humidity, which gives customers the chance to perform additional studies of their product’s longevity during the aging process. These conditions are monitored 24/7 by our system, ensuring our customers’ products complete the aging process correctly.

Nelipak Laboratory Services also offers real-time aging testing. Products can be stored at ambient conditions, which are constantly monitored – providing customers with peace of mind that products can complete their aging without issues.

For further information regarding testing of accelerated aging and other services, contact the Nelipak Laboratory Services team at cla-labservices@nelipak.com or click here.

###

About Nelipak® Corporation

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; Elsham, United Kingdom; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak® Healthcare Packaging designs, develops and manufactures custom packaging products that provide superior protection for medical devices and pharmaceuticals.   Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world.  With over 1,400 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak® Laboratory Services is a trade name of Nelipak Corporation

Follow us on:

Twitter: www.twitter.com/nelipak1953 
LinkedIn: https://www.linkedin.com/company/nelipak
YouTube: www.youtube.com/user/nelipakhealthcare

Nelipak Marketing Contact:
Seán Egan
Director of Global Marketing
Nelipak Healthcare Packaging
+353-91-709-163
sean.egan@nelipak.com

Press Contact:
Sage Morander
SVM Public Relations
sage.morander@svmpr.com

                

Nelipak Laboratory Services Completed Validation of New Climatic Conditioning Chamber

Equipment Meets Increased Customer Demand for Condition Testing

Clara, Ireland January 26, 2021 Nelipak® Laboratory Services (“Nelipak”), a leading provider of healthcare packaging testing for the medical device and pharmaceutical sectors, today announced that Nelipak Laboratory Services has completed the validation of our new climatic conditioning chamber to meeting increased demand for conditioning testing.

With the new MDR regulations coming into effect in May 2021, OEMs find themselves requiring a full validation of their shipping containers to ensure products reach clients in perfect condition.

Climatic conditioning plays a vital role in assessing a shipper’s strength and suitability for transport around the globe. The most requested standards are ASTM D4332 or ASTM F2825, which detail the types of conditions packaging may be subjected to depending on the countries where products are sold. Whether shipping to hot and humid tropics or freezing tundra, it is vital to know a shipper can maintain its integrity and protect the product throughout its journey from manufacturer to final customer.

This new chamber can hold temperatures from -40 to 80 degrees and humidity’s from 0 – 90 % RH, which expands Nelipak’s capacity to supply all customers’ conditioning needs. This new large chamber (with a holding volume of 6.7m3) increases our ability to condition a large amount of customer product in one setting, greatly speeding up lead- times to customers.

For further information regarding testing of transportation containers and other services, click here. To speak to one of our expert team members or for more information on our services contact cla-labservices@nelipak.com.

###

About Nelipak® Corporation

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; Elsham, United Kingdom; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak® Healthcare Packaging designs, develops and manufactures custom packaging products that provide superior protection for medical devices and pharmaceuticals.   Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world.  With over 1,400 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak® Laboratory Services is a trade name of Nelipak Corporation

Follow us on:

Twitter: www.twitter.com/nelipak1953 
LinkedIn: https://www.linkedin.com/company/nelipak
YouTube: www.youtube.com/user/nelipakhealthcare

Nelipak Marketing Contact:
Seán Egan
Director of Global Marketing
Nelipak Healthcare Packaging
+353-91-709-163
sean.egan@nelipak.com

Press Contact:
Sage Morander
SVM Public Relations
sage.morander@svmpr.com

                

Nelipak Appoints Pat Chambliss as Chief Executive Officer; Roger Prevot to continue as Chairman of the Board of Directors

Nelipak Appoints Pat Chambliss as Chief Executive Officer

Cranston, RI – January 4, 2021 – Nelipak® Corporation (“Nelipak”), a global leader in rigid and flexible packaging for the medical device and pharmaceutical sectors, announced today that Pat Chambliss has been named the company’s Chief Executive Officer. Chambliss, current President and Chief Operating Officer of Nelipak, brings to the Chief Executive Officer role an extensive track record of senior leadership experience in the packaging industry, including previous roles at Packaging Dynamics Corporation and Novolex.  Chambliss commented, “I look forward to leading Nelipak into the next phase of its development with a continued drive to excellence in innovation, growth and operational execution.”

Chambliss will succeed Roger Prevot as the company’s Chief Executive Officer. Prevot will continue in his role as Chairman of the Board of Directors, a position he has held since the acquisition of Nelipak by Kohlberg & Company in July 2019. Prevot commented, “I’ve had the opportunity to work alongside Pat for many years, and his distinguished track record and strong professional and personal values makes him an outstanding successor to lead Nelipak into the future. I am proud of the accomplishments we have achieved at Nelipak and I am excited to see continued success under Pat’s leadership.”

Seth H. Hollander, Partner of Kohlberg, commented, “On behalf of the Board of Directors of Nelipak, I wish to sincerely thank Roger for his distinguished service to the company and look forward to his continued role as Chairman of the Board of Directors. Roger has been instrumental in the creation of the current Nelipak and integration of the former European Healthcare Packaging business of Bemis Corporation. As a result of his vision, Nelipak is well-positioned to continue to execute upon transformational initiatives and drive continued excellence.” Hollander continued, “As President and COO, Pat has been instrumental in leading day-to-day operations including initiatives which position the business for future growth through internal investment and strategic acquisitions. Pat’s promotion to CEO is a natural progression that reflects his successful leadership at Nelipak. We are excited for him to step into the CEO role and lead Nelipak through its next phase of growth.”

For further information on Nelipak and its various products, please visit omsneladoptprd.wpenginepowered.com.

About Nelipak® Healthcare Packaging

Nelipak Healthcare Packaging is a leading global manufacturer of custom-designed rigid and flexible healthcare packaging used for Class II and Class III medical devices, and pharma drug delivery products. The company operates strategically located cleanroom facilities meeting customers’ most stringent packaging requirements. Nelipak’s experienced in-house design, development, prototyping, manufacturing and quality teams offer medical trays and blisters, surgical procedure trays, flexible sterile tray lidding and barrier pouches, pharmaceutical handling trays, custom built sealing machines and other value-added services. With a staff of over 1,400, the company operates from ten production facilities, five in the Americas (Cranston, RI.; Whitehall, PA; Phoenix, AZ.; Humacao, Puerto Rico; and San Jose, Costa Rica) and five in Europe (Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; and Elsham, England).  For more information please visit omsneladoptprd.wpenginepowered.com.

Nelipak® Healthcare Packaging is a trade name of Nelipak Corporation

About Kohlberg & Company, LLC

Kohlberg & Company, LLC (“Kohlberg”) is a leading private equity firm headquartered in Mount Kisco, New York. Since its inception in 1987, Kohlberg has organized nine private equity funds, through which it has raised over $10 billion of committed equity capital. Over its 33-year history, Kohlberg has completed 82 platform investments and nearly 200 add-on acquisitions, with an aggregate transaction value in excess of $20 billion.  For more information, please visit www.kohlberg.com.

Follow us on:

Twitter: www.twitter.com/nelipak1953 
LinkedIn: https://www.linkedin.com/company/nelipak
YouTube: www.youtube.com/user/nelipakhealthcare

Nelipak Marketing Contact:
Seán Egan
Director of Global Marketing
Nelipak Healthcare Packaging
+353-91-709-163
sean.egan@nelipak.com

Press Contact:
Jordan Bouclin
SVM Public Relations
jordan.bouclin@svmpr.com